semaglutide centerville Compound – Alliant LTC Pharmacy Sustainable results require medical oversight.,

We will record your height, weight, and blood pressure

The 19 identified GLP-1 RA-related NAEs are not documented in approved labeling, expanding on prior evidence

For instance, how much more weight did patient A lose than patient B over the period when A took the drug but B did not

The most commonly reported ones include: Upset stomach or nausea: Due to the slowed gastric motility, patients may feel full longer, which can cause discomfort

Further, several CVOTS evaluating GLP-1 RAs 8,9,13 and SGLT2 inhibitors 14,15 have documented significantly reduced CV event rates compared to placebo

In addition to initial FLOW trial findings indicating Ozempic can offer kidney protective benefits, results of Novo Nordisks SELECT trial showed that semaglutide significantly reduced rates of kidney and cardiovascular events compared with placebo in participants with overweight and obesity with cardiovascular disease but without diabetes